NanoViricides (NNVC)
(Delayed Data from AMEX)
$1.42 USD
+0.07 (5.19%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $1.41 -0.01 (-0.70%) 5:40 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.42 USD
+0.07 (5.19%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $1.41 -0.01 (-0.70%) 5:40 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Company News for Sep 28, 2021
by Zacks Equity Research
Companies in the news are: BYND, RCAT, ITCI, NNVC
Company News for May 13, 2020
by Zacks Equity Research
Companies In The News Are: GMDA, NNVC, CHAP, YRCW
Can Biotech ETFs Continue to Soar in 2020?
by Neena Mishra
We discuss coronavirus, cancer drugs, gene therapies, crispr and related biotech stocks & ETFs.
Company News For Jan 28, 2020
by Zacks Equity Research
Companies In The News Are:
3 Biotech Stocks Likely to Gain as Coronavirus Spreads
by Zacks Equity Research
Here we discuss three biotech stocks, which are likely to benefit in case there is an outbreak of coronavirus infection in China.
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech
Coronavirus Infects Wall Street: Stocks to Gain & Lose
by Tirthankar Chakraborty
While travel-related stocks were hit hard on concerns over coronavirus, experimental vaccine companies rallied.